Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	25944
Country	United States

Received	2016-03-26 15:18
Peer-Review Started	2016-03-27 12:22
To Make the First Decision	2016-05-17 12:17
Return for Revision	2016-05-18 11:09
Revised	2016-07-01 00:00
Second Decision	2016-08-18 09:57
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-08-29 11:54
Articles in Press	2016-08-29 11:54
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-09-28 13:13
Publish the Manuscript Online	2016-09-30 13:34

ISSN	1948-5204 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Review
Article Title	Current debate in the oncologic management of rectal cancer
Manuscript Source	Invited Manuscript
All Author List	Trish Millard, Paul R Kunk, Erika Ramsdale and Osama E Rahma
Funding Agency and Grant Number
Corresponding Author	Osama E Rahma, MD, Assistant Professor, Center for Immuno-Oncology/GI Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, M1B13, Boston, MA 02215, United States. osamae_rahma@dfci.harvard.edu
Key Words	Chemoradiation; Immunotherapy; Non-operative management; Neoadjuvant chemotherapy; Rectal cancer
Core Tip	Numerous controversies exist within the treatment of locally advanced rectal cancer. This review article summarizes the relevant evidence for rectal cancer treatment and offers opinions on how to interpret the data in clinical practice. Additional information is provided on novel areas of interest that are being actively explored such as the role of immunotherapy, the need for biomarkers, and the non-operative management.
Publish Date	2016-09-30 13:34
Citation	Millard T, Kunk PR, Ramsdale E, Rahma OE. Current debate in the management of rectal cancer. World J Gastrointest Oncol 2016; 8(10): 715-724
URL	http://www.wjgnet.com/1948-5204/full/v8/i10/715.htm
DOI	http://dx.doi.org/10.4251/wjgo.v8.i10.715

Full Article (PDF)	WJGO-8-715.pdf
Full Article (Word)	WJGO-8-715.doc
Manuscript File	25944-Review.docx
Answering Reviewers	25944-Answering reviewers.pdf
Audio Core Tip	25944-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	25944-Conflict-of-interest statement.pdf
Copyright License Agreement	25944-Copyright assignment.pdf
Peer-review Report	25944-Peer-review(s).pdf
Scientific Misconduct Check	25944-Scientific misconduct check.pdf
Scientific Editor Work List	25944-Scientific editor work list.pdf